- Buys
- 0 of 4
- Three Buys are needed, so MPT stays out of the basket.
- Secured notes placed
- $2.4B
- Repaid the 2026 notes and half of the 2027 notes.
- NFFO per share, third quarter
- $0.11
- Down from $0.13. HSA's missed rent cost two cents.
- Operating cash flow yield
- 14.0%
- Fiscal 2025 operating cash flow on a $1.64B market value.
Quality, decade-long holdingA levered landlord to fragile operators, with no moat to hold for ten years.
Deep value, margin of safetyA haircut under 20% on March assets erases the gap to the market value.
Macro and reflexivityThe maturity wall moved and a quarter of the shares are short. The 10-Q decides.
GrowthSelling the best hospitals to pay debt shrinks the base that has to grow.
Session of October 29, 2026. All four seats answered. The committee has not sat on Medical Properties Trust before.
Bottom line
Medical Properties Trust spent the third quarter fixing the problem that nearly broke it. The same release showed a new one. The 2026 debt is gone. A tenant on about 8% of the company's assets did not pay its September rent.
We read the price as a bet on rent collection, not on the balance sheet. On our arithmetic, the market value already allows operating cash flow to shrink about 8% a year for a decade. Management guides to cash rents above $1.0B in 2027. Two seats expect more cash than the price needs and still would not buy.
The split is whether the refinancing ended the spiral or only moved its date. The September debt total and the coupon on the new notes arrive in the 10-Q, due by November 9, 2026, and that filing tests both sides first.
The business in 60 seconds
MPT owns hospital buildings and leases them to operators. Rent is about 95% of revenue; the rest is interest on tenant loans and stakes in tenant businesses (10-K, filed February 26, 2026). At September 30, 2026, it held 365 properties leased to 52 operators in nine countries. Of roughly $14.4B of assets, $8.3B is general acute care (Exhibit 99.1, October 29, 2026).
The tenant list explains the losses. Steward Health Care filed for bankruptcy on May 6, 2024, and Prospect Medical on January 11, 2025, and the 10-K ties the 2024 and 2025 impairments to both. HSA took over the former Steward hospitals in September 2024. At December 31, 2025, the five largest tenants were Circle (14.1% of total assets), Priory (8.7%), HSA (8.0%), Swiss Medical (5.8%) and Lifepoint Behavioral (5.4%).
No holder controls the company: the 2026 proxy lists Vanguard near 11.5% and BlackRock near 11.3%, from their 13G/A filings, and two individuals above 5%. There is one share class, and the chief executive chairs the board (DEF 14A, filed April 13, 2026).
| Fiscal year | Revenue | Net income | Operating cash flow | Diluted shares |
|---|---|---|---|---|
| 2021 | $1.5B | $656.0M | $811.7M | 590.1M |
| 2022 | $1.5B | $902.6M | $739.0M | 598.8M |
| 2023 | $871.8M | -$556.5M | $505.8M | 598.5M |
| 2024 | $995.5M | -$2.4B | $245.5M | 600.2M |
| 2025 | $972.0M | -$277.0M | $230.8M | 600.9M |
Annual 10-K figures from SEC EDGAR. Operating income and capital spending are not tagged in the filings, so operating margin and free cash flow cannot be shown.
What changed
- The near maturities are refinanced. The secured notes repaid the 2026 notes and about half of the 2027 notes, with a $70M gain (Exhibit 99.1, October 29, 2026). Their cost is not in the release.
- Two sales closed above cost. Two Idaho hospitals went to Intermountain Health affiliates for about $371M and the last Utah interest for about $174M. Quarter sales brought about $680M of cash and a $158M gain (Exhibit 99.1).
- HSA stopped paying. The release says revenue cycle problems "precluded payment of September rent". HSA has hired Ovation Healthcare to run operations, and MPT gave it more working capital.
- Guidance held. The company "continues to expect portfolio cash rents in excess of $1.0 billion in 2027", after the sales and with conservative assumptions for HSA (Exhibit 99.1).
- The big operators are absorbing a payer shift. HCA put the cost of patients losing exchange coverage at about $400M of quarterly pre-tax income, while admissions rose 2.7% (HCA Exhibit 99.1, October 27, 2026). Universal Health Services grew net revenues 5.3% while net income fell to $308.7M from $373.0M (UHS Exhibit 99.1, October 27, 2026). MPT's tenants are smaller than either.
The bull case on Medical Properties Trust
- The calendar that drove the spiral moved out. The next forced event is years away, not months.
- Buyers paid above book. The $158M gain is this year's only market test of carrying value, and it cleared.
- The rent base is guided to hold. Above $1.0B in 2027 roughly matches fiscal 2025 revenue, on fewer assets.
- The dividend is covered. $0.09 a quarter against $0.11 of NFFO.
- Positioning is one-sided. Short interest was 24.98% of shares on October 15 (FINRA).
The market appears to be pricing the 2024 company with the 2026 balance sheet.
Investor C, Watch, on what the placement changed
The bear case on Medical Properties Trust
- Recurring earnings are still falling. NFFO was $64M against $77M; the $202M net income includes $228M of one-off gains.
- The landlord is funding a tenant that cannot pay it. Working capital to HSA while HSA misses rent is rent recycled, not collected.
- Secured debt moved ahead of the common. Pledged assets leave less for the equity in the next stress.
- Selling the best assets shrinks the base. The hospitals a strong system will buy are the ones with the best tenants.
The remaining portfolio is losing quality faster than debt is being retired.
Investor D, Avoid
Financing flexibility cannot permanently substitute for tenants paying rent from their own operations.
Investor B, Avoid, on its weakest link
Where the committee splits
No seat voted Buy, and two questions separate the three Avoids from the Watch.
Did the refinancing end the spiral, or reschedule it?
| Position | Seats | The figure it rests on |
|---|---|---|
| Ended, pending proof | C | 2026 notes and half of the 2027 notes repaid (Exhibit 99.1) |
| Rescheduled at a higher rank | A, B, D | $2.4B of secured notes ahead of the common |
What settles it. The 10-Q due by November 9, 2026: total debt at September 30, the coupon on the secured notes and the unencumbered asset pool.
From the chair, to Investor C. Your trigger is an interest burden that fits inside the current NFFO run rate. What coupon on the $2.4B would push NFFO below the $0.09 dividend, and does the Watch survive a 10-Q that shows it?
From the chair, to Investor A. If the 10-Q shows debt under $8.5B, which of your other breakers still holds you at Avoid?
Are the assets worth their book value?
| Position | Seats | The figure it rests on |
|---|---|---|
| No margin until proven | B | $14.76B of assets against $10.22B of liabilities, March 31, 2026 |
| Sales show value holds | C | $680M of sales at a $158M gain (Exhibit 99.1) |
| The best assets are going first | D | Same sales, read as the strongest tenants leaving |
What settles it. Impairment charges and sale prices against carrying value in the 10-Q and the fiscal 2026 10-K, due by March 1, 2027.
From the chair, to Investor B. The only assets a buyer tested this quarter cleared book by $158M. Why does a 25% haircut apply to the whole portfolio rather than to the cash-basis tenants?
From the chair, to Investor D. What disclosure would show the rent coverage of what remains, and if it held, does the Avoid stand?
| Investor | Verdict | What breaks its thesis |
|---|---|---|
| A | Avoid 8 | Three of: debt below $8.5B at September 30; NFFO of $0.13 for two quarters; HSA paying without support; fiscal 2026 operating cash flow above $300M. That moves it to Watch, not Buy |
| B | Avoid 6 | Equity at or below $1.64B, or debt at or above $9.66B, in the 10-Q. Unsupported tenant collections move it toward Watch |
| C | Watch 6 | Another unpaid HSA month; 2027 rent guidance at or below $1.0B; a dividend under $0.09; the high-yield spread above 4.50% for two monthly prints; fiscal 2026 operating cash flow below $200M |
| D | Avoid 8 | Annualized cash rents below $950M in the first-quarter 2027 10-Q; fiscal 2026 operating cash flow below $150M. Full rent from all top tenants without support moves it to Buy |
Valuation
What the price requires. This is our arithmetic, which the seats never saw. Free cash flow is not tagged, so the base is fiscal 2025 operating cash flow of $230.77M, which overstates it: acquisitions and tenant loans are not deducted. At 9.5%, the 10-year yield of 4.99% plus 4.5 points, the market value needs that cash to fall 8.0% a year for ten years and then grow 3%. Year three lands at $180M. At 8.5% it is a 9.8% yearly decline and $170M; at 10.5%, 6.4% and $190M.
That cash is after interest, so its yield is an equity figure; on a $10.9B enterprise value the equity is about 15% of the capital, against a 10-year yield of 4.99%.
Hatched bars are what the market value needs at three discount rates. Investor B is left off: its figure is owner earnings after depreciation, a different and negative base.
| Investor | Bear | Base | Bull | Weighted, year 3 | Against the price |
|---|---|---|---|---|---|
| A | 45%, $150M | 40%, $230M | 15%, $320M | $208M | above the band |
| B | 40%, -$100M | 40%, $0 | 20%, $150M | -$10M | below the band |
| C | 30%, $150M | 45%, $230M | 25%, $270M | $216M | above the band |
| D | 35%, -$100M | 50%, $160M | 15%, $350M | $98M | below the band |
A and C project operating cash flow, D free cash flow, B owner earnings after maintenance for fiscal 2029. C's bear case is $150M or below.
Two seats sit above the band and two below; guidance covers only 2027 rent. Neither seat above it voted Buy. Investor A will not price it, and Investor C is waiting for one filing:
My conclusion is that this is a recovery and refinancing situation, not a compounding business. My framework is not built to price it, so I pass.
Investor A, Avoid
the November 9 10-Q itself is the trigger that converts Watch to Buy if the interest burden fits inside the existing NFFO run-rate and HSA has paid.
Investor C, Watch
| Investor | Entry discipline |
|---|---|
| A | Under about 5x trailing NFFO, once net debt is below half of gross assets |
| B | No more than 6x verified normalized owner earnings, a 16.7% owner-earnings yield |
| C | Under about 5.5x annualized NFFO with HSA current, or a dividend yield 900 basis points over the 10-year |
| D | Fixed-charge coverage above 2.0x and organic revenue growth without sale gains |
Comparables
Four US healthcare landlords ran, but too few figures filled for a table. Omega Healthcare grew revenue 13.2% in its last fiscal year and Sabra 25.4%, while Universal Health Realty grew 0.2% and MPT shrank 2.4%. All four peers are profitable on trailing earnings, at 16.1x to 74.4x, and MPT is not. The gap is a tenant list with two bankruptcies in two years, not the asset class.
For a different case of thin equity under heavy fixed claims, see our Wendy's review.
Key risks
Ranked by us, most severe first. Raised by lists each source that named the risk.
| Risk | Why it matters | Raised by | First signal |
|---|---|---|---|
| High. Tenant credit, led by HSA | Rent stops while debt service does not | Exhibit 99.1, Analyst, Investors A, B, C and D; forum (unverified) | A second unpaid HSA month or more support, in the 10-Q |
| High. Secured layering | Pledged assets sit ahead of the common in the next stress | Analyst, Investors A and B | Unencumbered asset pool in the 10-Q |
| High. Payer mix and reimbursement at tenants | Smaller operators lose the margin that pays rent | 10-K Item 1A, HCA and UHS releases, Analyst, Investors B, C and D | Another tenant moved to cash basis |
| Medium. A shrinking base from sales | Each sale removes rent as well as debt | Analyst, Investor D | Fourth-quarter NFFO per share against $0.09 |
| Medium. Credit spreads reopen the wall | Half of the 2027 notes still need refinancing | Investor C, Analyst | High-yield spread above 4.50% |
| Medium. Governance and pay | Pay tied to deals, not per-share value | DEF 14A, Analyst, Investors A and C | Pay measures in the 2027 proxy |
What to watch
| Date | Event | What it decides |
|---|---|---|
| By November 9, 2026 | Third-quarter 10-Q, SEC deadline | September debt, the secured note coupon, HSA |
| Ongoing | Next quarterly dividend declaration, on company release | Whether $0.09 holds |
| By March 1, 2027 | Fiscal 2026 10-K, SEC deadline for large accelerated filers | Operating cash flow against the seats' $150M, $200M and $300M lines |
| By March 1, 2028 | Fiscal 2027 10-K (SEC deadline) | Whether cash rents exceeded $1.0B as guided |
Owning it onchain
xStocks issues a tokenized version, MPTx. We have not judged whether it is investable: when we checked, before regular US trading opened on October 29, 2026, no market maker was quoting it.
Data
| Item | Figure | Source |
|---|---|---|
| Share price | $2.75, October 28, 2026 close | Yahoo Finance |
| Shares outstanding | 598,100,000 at May 6, 2026 | SEC EDGAR cover data |
| Market value | $1.64B | Price times shares |
| 10-year Treasury yield | 4.99%, October 27, 2026 | FRED |
| Enterprise value | $10.9B | Market value plus March 31 net debt, SEC EDGAR |
Method. Four investors with different philosophies, each on a different AI model, read one identical fact sheet and voted independently. A name needs three Buys to enter a basket. How the committee works.
Correction. This article first said MPTx was not investable because a check before regular US trading opened found no buy quote. Market makers quote thinly or not at all at that hour. We now judge that cost only during regular US market hours, and we have removed that verdict.
As of October 29, 2026, BagsCapital manages no outside capital and holds no position in Medical Properties Trust. Nothing here is investment advice.